| 000 | 01641 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513153319.0 | ||
| 264 | 0 | _c19981112 | |
| 008 | 199811s 0 0 eng d | ||
| 022 | _a0161-5505 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aElhendy, A | |
| 245 | 0 | 0 |
_aSafety of dobutamine-atropine stress myocardial perfusion scintigraphy. _h[electronic resource] |
| 260 |
_bJournal of nuclear medicine : official publication, Society of Nuclear Medicine _cOct 1998 |
||
| 300 |
_a1662-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAtropine |
| 650 | 0 | 4 |
_aCoronary Disease _xdiagnostic imaging |
| 650 | 0 | 4 | _aDobutamine |
| 650 | 0 | 4 | _aFeasibility Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart _xdiagnostic imaging |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypotension _xetiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOrganophosphorus Compounds |
| 650 | 0 | 4 | _aOrganotechnetium Compounds |
| 650 | 0 | 4 | _aRadiopharmaceuticals |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSafety |
| 650 | 0 | 4 |
_aTachycardia _xetiology |
| 650 | 0 | 4 | _aTechnetium Tc 99m Sestamibi |
| 650 | 0 | 4 | _aThallium Radioisotopes |
| 650 | 0 | 4 | _aTomography, Emission-Computed, Single-Photon |
| 700 | 1 | _aValkema, R | |
| 700 | 1 | _avan Domburg, R T | |
| 700 | 1 | _aBax, J J | |
| 700 | 1 | _aNierop, P R | |
| 700 | 1 | _aCornel, J H | |
| 700 | 1 | _aGeleijnse, M L | |
| 700 | 1 | _aReijs, A E | |
| 700 | 1 | _aKrenning, E P | |
| 700 | 1 | _aRoelandt, J R | |
| 773 | 0 |
_tJournal of nuclear medicine : official publication, Society of Nuclear Medicine _gvol. 39 _gno. 10 _gp. 1662-6 |
|
| 999 |
_c9740955 _d9740955 |
||